Proceedings of the Texas A&M Medical Student Grand Rounds

Role of Microglia-Derived Extracellular Vesicles (EVs) in Spreading Alzheimer’s Disease Pathophysiology

May 31, 2024 Maha Kirmani

Maha Kirmani

Background: Alzheimer’s disease, primarily affecting the elderly, is characterized by Aβ plaques, Tau neurofibrillary tangles, and synaptic loss starting in the entorhinal cortex and spreading across the cortex.1 Risk factors include age, education level, chronic stress, and elevated glucocorticoids. It has two subtypes: Sporadic/late-onset (SAD), associated with lifestyle and genetic factors like APOE4 mutations, and Familial AD (FAD), an autosomal dominant form linked to mutations in APP and presenilin. 2,3  Recent therapeutics have focused on AB plaque clearance and symptomatic treatment, but none halt AD progression. Additionally, there is an absence of correlation between PET amyloid level and cognition function, suggesting AB may be a pathological sign of AD, rather than a cause of cognitive decline.4 There is increasing evidence that conjecture neuroinflammation precedes the formation of both amyloid plaques and tau protein hyperphosphorylation, activating glial cells and worsening AD progression5.

Objective: In this narrative review, we explored the mechanisms by which Microglia-derived EVs spread Alzheimer’s disease pathophysiology.

Search Methods: An online search in the PubMed database was conducted from 2018 to 2024 using the following keywords: “Alzheimer’s disease”, ” extracellular-vesicles”, ” amyloid-beta”, and “microglia”.

Results: Murine microglia exposed to Aβ42 for 20 hrs and activated with 1 mM ATP released Aβ-EVs. The effects of AB-EVs derived from microglia on dendritic spines were investigated, after placing EVs on hippocampal neurons via optical tweezers. The attachment of Aβ-EVs externally induced dendritic spine thinning, favoring immature structures. Treated neurons showed impaired synaptic plasticity, lacking sustained mEPSC frequency increase compared to controls. Annexin-V coating inhibited EV extracellular movement and signaling, reducing motion by 41% and preventing LTP blockage propagation. Aβ-EVs moved extracellularly anterogradely along axonal surfaces, contrary to the retrograde motion of the control-EVs, and Annexin-V blocked this motion. To investigate Aβ-EVs’ role in spreading synaptic dysfunction, Long-term Potentiation (LTP) was measured in the entorhinal cortex (EC) and the ipsilateral Dentate Gyrus. LTP was blocked in the entorhinal cortex (EC) at both 1 hr and 24 hr intervals, spreading to the PP-DG synapse at 24 hr, suggesting that LTP impairment spread between the two interconnected regions. Unilateral injection of oligomeric Aβ42 did not propagate LTP blockage or induce lasting impairment across brain regions.6

Conclusions: Aβ42-enriched large extracellular vesicles (EVs) released by microglia affect dendritic spine size in cultured neurons, cause impaired synaptic plasticity within both cultured cells and brain slices, and propagate impairment of long-term potentiation (LTP) throughout the entorhinal–hippocampal circuitry. This study points to a significant role for large microglial EVs, carrying surface Aβ in the propagation of synaptic dysfunction, and can be the target for future therapeutic applications.

Works Cited:

  1. Ruan Z. Extracellular vesicles drive tau spreading in Alzheimer’s disease. Neural Regen Res. 2022;17(2):328-329. doi:10.4103/1673-5374.317975
  2. Gomes P, Tzouanou F, Skolariki K, et al. Extracellular vesicles and Alzheimer’s disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment. Exp Neurol. 2022;358:114183. doi:10.1016/j.expneurol.2022.114183
  3. Zhang T, Ma S, Lv J, et al. The emerging role of exosomes in Alzheimer’s disease. Ageing Res Rev. 2021;68:101321. doi:10.1016/j.arr.2021.101321
  4. Qiao Y, Chi Y, Zhang Q, Ma Y. Safety and efficacy of lecanemab for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. Front Aging Neurosci. 2023;15:1169499. Published 2023 May 5. doi:10.3389/fnagi.2023.1169499
  5. Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359. Published 2023 Sep 22. doi:10.1038/s41392-023-01588-0
  6. Gabrielli M, Prada I, Joshi P, et al. Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease. Brain. 2022;145(8):2849-2868. doi:10.1093/brain/awac083

 

Featured Abstracts Neuroscience
Previous Post

The Use of Antibody-Drug Conjugates to Overcome the Drug Resistance of HER2+ Breast Cancer Caused by Tumor Heterogeneity

Next Post

The Use of Bioengineered Outer Membrane Vesicle Vaccines Derived from Gram-Negative Bacteria to Prevent Meningococcal Meningitis

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.